AMY ASHLEY: Open Payments
NPI 1811327612 · WEWOKA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 9 payments from 4 companies in 2025. Trend: 2023 $208 · 2024 $370 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Alkermes, Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, ARISTADA, INGREZZA, REXULTI.
Industry payments across OK — which companies pay providers there.
